AU3212700A - Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancer - Google Patents

Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancer

Info

Publication number
AU3212700A
AU3212700A AU32127/00A AU3212700A AU3212700A AU 3212700 A AU3212700 A AU 3212700A AU 32127/00 A AU32127/00 A AU 32127/00A AU 3212700 A AU3212700 A AU 3212700A AU 3212700 A AU3212700 A AU 3212700A
Authority
AU
Australia
Prior art keywords
therapeutic
prostate cancer
acid phosphatase
diagnostic applications
prostatic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32127/00A
Inventor
Ming-Fong Lin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nebraska
Original Assignee
University of Nebraska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nebraska filed Critical University of Nebraska
Publication of AU3212700A publication Critical patent/AU3212700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
    • C12Y301/03002—Acid phosphatase (3.1.3.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU32127/00A 1999-01-21 2000-01-21 Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancer Abandoned AU3212700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11655199P 1999-01-21 1999-01-21
US60116551 1999-01-21
PCT/US2000/001599 WO2000043548A1 (en) 1999-01-21 2000-01-21 Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancer

Publications (1)

Publication Number Publication Date
AU3212700A true AU3212700A (en) 2000-08-07

Family

ID=22367878

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32127/00A Abandoned AU3212700A (en) 1999-01-21 2000-01-21 Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancer

Country Status (2)

Country Link
AU (1) AU3212700A (en)
WO (1) WO2000043548A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20041453A0 (en) * 2004-11-11 2004-11-11 Pirkko Vihko Knockout Animals
WO2008112283A2 (en) * 2007-03-12 2008-09-18 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Microrna profiling of androgen responsiveness for predicting the appropriate prostate cancer treatment
GB2484058A (en) * 2009-12-01 2012-04-04 Uni Konstanz Prostate cancer DNA vaccine
CN113711991A (en) * 2020-11-02 2021-11-30 江门赛尔康生物科技有限公司 Construction method and application of PAP (PAP) -targeted drug screening animal model
CN113455465B (en) * 2021-06-29 2023-02-28 安徽省立医院(中国科学技术大学附属第一医院) Method for constructing nude mouse subcutaneous transplantation model of human prostate cancer LNCaP cell

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162504A (en) * 1988-06-03 1992-11-10 Cytogen Corporation Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients
US5773215A (en) * 1989-10-24 1998-06-30 Board Of Regents, The University Of Texas System Tumor marker protein for cancer risk assessment
US5935818A (en) * 1995-02-24 1999-08-10 Sloan-Kettering Institute For Cancer Research Isolated nucleic acid molecule encoding alternatively spliced prostate-specific membrane antigen and uses thereof
US5882864A (en) * 1995-07-31 1999-03-16 Urocor Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
US5763415A (en) * 1995-08-03 1998-06-09 John Hopkins University School Of Medicine Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer

Also Published As

Publication number Publication date
WO2000043548A1 (en) 2000-07-27

Similar Documents

Publication Publication Date Title
AU7994200A (en) Compositions and methods for therapy and diagnosis of prostate cancer
AU1656501A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2001249549A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
IL140845A0 (en) Compositions for therapy and diagnosis of prostate cancer
HUP0203968A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU1807401A (en) Compositions and methods for therapy and diagnosis of breast cancer
AU2003302892A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AUPQ923100A0 (en) Treatment of prostate cancer
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU6502199A (en) Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
IL136167A0 (en) Conjugates useful in the treatment of prostate cancer
AUPQ201499A0 (en) Treatment of inflammatory and malignant diseases
AU3212700A (en) Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancer
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2238499A (en) Androgen-metabolic gene mutations and prostate cancer risk
AU2193797A (en) Delivery of therapeutic agents to the prostate
AU1490801A (en) Targeted delivery of therapeutic and diagnostic moieties
AU6111800A (en) 26 human prostate and prostate cancer associated proteins
AU4452900A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2001271284A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
ZA9810974B (en) Conjugates useful in the treatment of prostate cancer
AU2001296224A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase